MAERL accelerates atherosclerosis by inhibiting macrophage efferocytosis via transglutaminase 2.
- DOI
- 10.3724/abbs.2026092
- Published
- 2026 Oct 14
- Container
- Acta biochimica et biophysica Sinica
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3724/abbs.2026092,
title = {MAERL accelerates atherosclerosis by inhibiting macrophage efferocytosis via transglutaminase 2.},
author = {Xiao K and Wang Y and Wu Q and Zhang Z and Li S and Yang J and Zhao X and Li G and Sun J and Ma F and Ma S and Zhang G},
year = {2026},
journal = {Acta biochimica et biophysica Sinica},
doi = {10.3724/abbs.2026092},
url = {https://doi.org/10.3724/abbs.2026092}
}RIS
TY - JOUR TI - MAERL accelerates atherosclerosis by inhibiting macrophage efferocytosis via transglutaminase 2. AU - Xiao K AU - Wang Y AU - Wu Q AU - Zhang Z AU - Li S AU - Yang J AU - Zhao X AU - Li G AU - Sun J AU - Ma F AU - Ma S AU - Zhang G PY - 2026 JO - Acta biochimica et biophysica Sinica DO - 10.3724/abbs.2026092 UR - https://doi.org/10.3724/abbs.2026092 ER -
APA
K, X., Y, W., Q, W., Z, Z., S, L., J, Y., X, Z., G, L., J, S., F, M., S, M., & G, Z. (2026). MAERL accelerates atherosclerosis by inhibiting macrophage efferocytosis via transglutaminase 2.. Acta biochimica et biophysica Sinica. https://doi.org/10.3724/abbs.2026092
Source records
- pubmed · retrieved 2026-11-10T14:02:58.611Z